Nel ASA: A Strong Order Book, a Shrinking Top Line, and the Gap Investors Must Watch

Nel ASA enters its next reporting cycle with two very different stories on the same page. One is a backlog that has swelled sharply. The other is a business that booked barely more than a third of last year's revenue. Which number ultimately matters more will depend on something neither figure can settle on its own: how quickly orders turn into deliveries, and deliveries into a healthier bottom line.

Liquidity Is a Cushion, Not a Comeback

The Norwegian hydrogen specialist closed the third quarter of 2026 with NOK 1,078 million in liquid funds. That is a meaningful financial reserve, and it gives the company room to maneuver. It says nothing, however, about whether the underlying operation has found its footing.

The income statement points the other way. Revenue from customer contracts fell 63% year on year to NOK 112 million. EBITDA came in at NOK -93 million, and the net loss reached NOK -141 million. Cash on hand and earnings power therefore need to be read as separate items — a healthy balance sheet describes the resources available, not the profitability of the business using them. Nor does a single quarterly loss, on its own, tell investors how far that reserve will stretch.

Orders Are Climbing — Revenue Is Not

Where the quarter did impress was on the demand side. Order intake jumped 339% to NOK 253 million, lifting the order backlog to NOK 1,314 million. That is a considerably stronger order base than a year ago, and it is the main argument for anyone betting on a recovery.

It is not, though, the same thing as revenue already earned. For a credible turnaround, the two sides of the ledger would need to converge: the existing backlog would have to flow into deliveries and services, while fresh orders sustain the pace of business. A large backlog by itself answers neither how fast execution will proceed nor how profitable those orders will prove. Revenue from customer contracts thus remains the metric to watch in the coming updates — a renewed rise would signal that the improved order picture is reaching the P&L, while backlog growth alone would leave the decisive test unmet.

Two Announcements, Two Very Different Weightings

The distinction between a firm order and an expression of interest is not academic here, and two announcements from roughly a week ago illustrate it neatly.

Nel Hydrogen US, the company's American subsidiary, secured an order worth about USD 12 million from an unnamed US technology company. The contract covers several containerized PEM electrolysers along with associated services, with delivery expected in 2027. That is a concrete customer commitment with a timeline attached — though the 2027 delivery date is itself part of the assessment, since the order should not be confused with revenue already booked.

The letter of intent signed with Rheinmetall carries far less certainty. The two companies intend to examine decentralized production of synthetic fuels based on renewable hydrogen, with an initial focus on Norway. The review covers technical and economic feasibility, possible sites and potential pilot projects. Any next steps depend on the findings and on mutual agreement, and no concrete deliveries have been announced. It opens a possible additional application for Nel's technology; it should not be treated as a secured contract.

What Would Make the Bull Case Hold

Behind part of the growth story sit real customer orders, and that is what gives the optimistic reading its footing. If contracts like the US electrolyser deal are executed as planned and further orders follow, the foundation for a recovery could firm up. The convincing version of that story would not be a single headline win but a pattern — Nel repeatedly working through orders while winning new demand at the same time. Only that combination would lend real weight to the surge in order intake.

The counterargument starts with the current pressure on results. The stronger ordering activity has not yet translated into positive earnings, so even a pick-up in revenue would not by itself dispel all doubts. Investors would also want to see losses narrow; rising sales paired with persistently weak profitability could cap the recovery thesis. A fresh decline in revenue, conversely, would show that the better order book is not yet offsetting operational weakness.

The Next Data Points

Progress on order execution is therefore the item to watch in upcoming business updates, with the 2027 delivery of the US order providing a concrete reference point. The Rheinmetall agreement could become a further catalyst if the feasibility review yields binding projects — but only then.

For shareholders, the decision comes down to weighing an early position against stronger operational confirmation. The order base offers arguments for a possible improvement. Whether it becomes a durable recovery is something Nel still has to demonstrate through execution — and through a top line that finally starts moving in the same direction as its backlog.